Ezra Lowe
Company: Galectin Therapeutics
Job title: Vice President, Clinical Pharmacology
Seminars:
Workshop E: Illuminating Novel Target Identification for MASH 2:30 pm
This presentation will discuss screening algorithms for trials with different fibrosis and NAS score criteria. Current VCTEbased algorithms, such as FAST, Agile 3, and Agile 4, are not optimized for trial-specific needs, leading to high screen fail rates from liver biopsy. The ALADDIN study addresses this gap by using machine learning models trained on various fibrosis and NAS cutoffs. It…Read more
day: Pre Clinical Track Workshop E